je.st
news
Remedy Pharmaceuticals Announces Contest To Name Its Subarachnoid Hemorrhage Clinical Trial
2016-06-08 04:14:03| drugdiscoveryonline News Articles
Remedy Pharmaceuticals, a privately-held pharmaceutical company focused on bringing life-saving hospital-based treatment to people affected by central nervous system (CNS) related edema, recently announced a contest to name its upcoming clinical trial in Subarachnoid Hemorrhage (SAH)
Tags: trial
clinical
contest
announces
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|